Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMpact of PCSK9 inhibitoR initiatiOn Before Percutaneous Coronary Intervention on Coronary microVascular Dysfunction and Events for Acute Myocardial Infarction: a Multi-center, Open-label, Randomized, Controlled Trial

NCT06683131 is registered in ClinicalTrials.gov with The Affiliated Hospital of Xuzhou Medical University as lead sponsor.

NCT NCT06683131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMpact of PCSK9 inhibitoR initiatiOn Before Percutaneous Coronary Intervention on Coronary microVascular Dysfunction and Events for Acute Myocardial Infarction: a Multi-center, Open-label, Randomized, Controlled Trial
Lead sponsor
The Affiliated Hospital of Xuzhou Medical University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 20, 2025
Completion date
November 30, 2027
Enrollment
1,160 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami)